{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:23:43Z","timestamp":1777577023081,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Institute of Chronic Illnesses, Inc"},{"name":"nonprofit CoMeD, Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hygiene and Environmental Health"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijheh.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T17:40:53Z","timestamp":1521394853000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States"],"prefix":"10.1016","volume":"221","author":[{"given":"David A.","family":"Geier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet K.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin G.","family":"Homme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Geier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijheh.2018.03.004_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1542\/peds.2003-1177-L","article-title":"Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association","volume":"114","author":"Andrews","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ijheh.2018.03.004_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/jpepsy\/jsr048","article-title":"Thimerosal exposure in early life and neuropsychological outcomes 7\u201310 years later","volume":"37","author":"Barile","year":"2012","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00002018-200528020-00001","article-title":"Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease","volume":"28","author":"Bigham","year":"2005","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archpedi.1996.02170300018004","article-title":"An errant critique that misses the mark","volume":"150","author":"Chen","year":"1996","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.104.3.570","article-title":"Thimerosal in vaccines \u2013 an interim report to clinicians","volume":"104","author":"Committee on Infectious Diseases and Committee on Environmental Health","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijheh.2018.03.004_bib0030","doi-asserted-by":"crossref","first-page":"132876","DOI":"10.1155\/2012\/132876","article-title":"Neurodevelopment of Amazonian infants: antental and postnatal exposure to methyl- and ethylmercury","volume":"2012","author":"Dorea","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/02772240701806501","article-title":"Hepatitis B triple series vaccine and developmental disability in US children aged 1\u20139 years","volume":"90","author":"Gallagher","year":"2008","journal-title":"Toxicol. Environ. Chem."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0040","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1080\/15287394.2010.519317","article-title":"Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997\u20132002","volume":"73","author":"Gallagher","year":"2010","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.ijheh.2018.03.004_bib0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15376520208951158","article-title":"The state of polio vaccination in the world: the case for continuing routine vaccination","volume":"12","author":"Geier","year":"2002","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ijheh.2018.03.004_bib0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1517\/14656566.5.3.691","article-title":"A review of the vaccine adverse event reporting system database","volume":"5","author":"Geier","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.ijheh.2018.03.004_bib0055","first-page":"CR231","article-title":"An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines","volume":"12","author":"Geier","year":"2006","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.ijheh.2018.03.004_bib0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-9158-2-25","article-title":"A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States","volume":"2","author":"Geier","year":"2013","journal-title":"Transl. Neurodegener."},{"issue":"10","key":"10.1016\/j.ijheh.2018.03.004_bib0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/1947-2714.143284","article-title":"Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalink","volume":"6","author":"Geier","year":"2014","journal-title":"N. Am. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.ijheh.2018.03.004_bib0070","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.3390\/ijerph110909156","article-title":"A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders","volume":"11","author":"Geier","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.ijheh.2018.03.004_bib0075","first-page":"64","article-title":"The risk of neurodevelopmental disorders following a Thimerosal-preserved DTaP formulation in comparison to its Thimerosal-reduced formulation in the vaccine adverse event reporting system (VAERS)","volume":"2","author":"Geier","year":"2014","journal-title":"J. Biochem. Pharmcol. Res."},{"issue":"2","key":"10.1016\/j.ijheh.2018.03.004_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1515\/intox-2015-0011","article-title":"Thimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study","volume":"8","author":"Geier","year":"2015","journal-title":"Interdiscip. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.ijheh.2018.03.004_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12011-014-0169-3","article-title":"A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States","volume":"163","author":"Geier","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cca.2015.02.030","article-title":"Thimerosal: clinical, epidemiologic and biochemical studies","volume":"444","author":"Geier","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ijheh.2018.03.004_bib0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jegh.2015.06.002","article-title":"A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: assessment of attributable risk and lifetime care costs","volume":"6","author":"Geier","year":"2016","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"1","key":"10.1016\/j.ijheh.2018.03.004_bib0100","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3390\/brainsci6010009","article-title":"Thimerosal-preserved hepatitis B vaccine and hyperkinetic syndrome of childhood","volume":"6","author":"Geier","year":"2016","journal-title":"Brain Sci."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0105","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.12659\/MSM.900257","article-title":"A two-phase case-control study of autism risk among children born from the late 1990 through the early 2000 in the United States","volume":"22","author":"Geier","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.ijheh.2018.03.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1177\/1559325817690849","article-title":"Abnormal connectivity spectrum disorders following thimerosal administration: a prospective longitudinal case-control assessment of medical records in the Vaccine Safety Datalink","volume":"15","author":"Geier","year":"2017","journal-title":"Dose Response"},{"issue":"9553","key":"10.1016\/j.ijheh.2018.03.004_bib0115","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(06)69665-7","article-title":"Developmental neurotoxicity of industrial chemicals","volume":"368","author":"Grandjean","year":"2006","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.ijheh.2018.03.004_bib0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1474-4422(13)70278-3","article-title":"Neurobehavioural effects of developmental toxicity","volume":"13","author":"Grandjean","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0125","doi-asserted-by":"crossref","first-page":"247218","DOI":"10.1155\/2014\/247218","article-title":"Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe","volume":"2014","author":"Hooker","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"13","key":"10.1016\/j.ijheh.2018.03.004_bib0130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.290.13.1763","article-title":"Association between thimerosal-containing vaccine and autism","volume":"290","author":"Hviid","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijheh.2018.03.004_bib0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2012-1887","article-title":"Evidence of parallels between mercury intoxication and the brain pathology in autism","volume":"72","author":"Kern","year":"2012","journal-title":"Acta Neurobiol. Exp. (Wars.)"},{"key":"10.1016\/j.ijheh.2018.03.004_bib0140","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.3390\/ijerph10083771","article-title":"Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism","volume":"10","author":"Kern","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"6","key":"10.1016\/j.ijheh.2018.03.004_bib0145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/brain.2014.0324","article-title":"Shared brain connectivity issues, symptoms, and comorbidities in autism spectrum disorder, attention deficit\/hyperactivity disorder, and Tourette syndrome","volume":"5","author":"Kern","year":"2015","journal-title":"Brain Connect."},{"issue":"6","key":"10.1016\/j.ijheh.2018.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11948-017-9983-2","article-title":"Systematic assessment of research on autism spectrum disorder (ASD) and mercury reveals conflicts of interest and the need for transparency in autism research","volume":"23","author":"Kern","year":"2017","journal-title":"Sci. Eng. Ethics"},{"key":"10.1016\/j.ijheh.2018.03.004_bib0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jtemb.2015.06.008","article-title":"Toxicity or organic and inorganic mercury species in differentiated human neurons and human astrocytes","volume":"32","author":"Lohren","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"3 Pt 1","key":"10.1016\/j.ijheh.2018.03.004_bib0160","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.112.3.604","article-title":"Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data","volume":"112","author":"Madsen","year":"2003","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ijheh.2018.03.004_bib0165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ntt.2012.10.001","article-title":"Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life","volume":"34","author":"Mrozek-Budzyn","year":"2012","journal-title":"Neurotoxicol. Teratol."},{"issue":"4","key":"10.1016\/j.ijheh.2018.03.004_bib0170","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1542\/peds.2010-0309","article-title":"Prenatal and infant exposure to Thimerosal from vaccines and immunologulins and risk of autism","volume":"126","author":"Price","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijheh.2018.03.004_bib0175","doi-asserted-by":"crossref","first-page":"373678","DOI":"10.1155\/2012\/373678","article-title":"Thimerosal-derived ethylmercury is a mitochondrial toxin in human astrocytes: possible role of Fenton chemistry in the oxidation and breakage of mtDNA","volume":"2012","author":"Sharpe","year":"2012","journal-title":"J. Toxicol."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0180","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group","volume":"17","author":"Singleton","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijheh.2018.03.004_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0749-3797(03)00113-2","article-title":"Autism and thimerosal-containing vaccines: lack of consistent evidence for an association","volume":"25","author":"Stehr-Green","year":"2003","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.ijheh.2018.03.004_bib0190","first-page":"206","article-title":"Thimerosal as discrimination: vaccine disparity in the UN Minimata Convention of mercury","volume":"11","author":"Sykes","year":"2014","journal-title":"Indian J. Med. Ethics"},{"issue":"1\u20132","key":"10.1016\/j.ijheh.2018.03.004_bib0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5173(00)00514-7","article-title":"Route of decomposition of thiomersal (thimerosal)","volume":"208","author":"Tan","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"13","key":"10.1016\/j.ijheh.2018.03.004_bib0200","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMoa071434","article-title":"Vaccine safety datalink team","volume":"357","author":"Thompson","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijheh.2018.03.004_bib0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.2008-0795","article-title":"Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines","volume":"123","author":"Tozzi","year":"2009","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ijheh.2018.03.004_bib0210","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.112.5.1039","article-title":"Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases","volume":"112","author":"Verstraeten","year":"2003","journal-title":"Pediatrics"},{"issue":"1\u20132","key":"10.1016\/j.ijheh.2018.03.004_bib0215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2008.04.002","article-title":"Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink","volume":"271","author":"Young","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijheh.2018.03.004_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2013.05.015","article-title":"Comparative study of methyl- and ethylmercury-induced toxicity in C6 glioma cells and the potential role of the lAT-1 in mediating mercurial-thiol complexes uptake","volume":"33","author":"Zimmermann","year":"2013","journal-title":"Neurotoxicology"}],"container-title":["International Journal of Hygiene and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463917307939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463917307939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:24:07Z","timestamp":1761413047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438463917307939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1438463917307939"],"URL":"https:\/\/doi.org\/10.1016\/j.ijheh.2018.03.004","relation":{},"ISSN":["1438-4639"],"issn-type":[{"value":"1438-4639","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States","name":"articletitle","label":"Article Title"},{"value":"International Journal of Hygiene and Environmental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijheh.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}